DMARDs not linked to Alzheimer’s risk for seniors with RA
Apr 12, 2022
No reduction in the risk for Alzheimer’s disease and related dementia was seen with treatment with tofacitinib, tocilizumab or tumor necrosis factor inhibitors versus abatacept.
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Wearable tech offers hope for spotting dementia-causing diseases
By
Kristen Fischer
Mar 11, 2024
Wearable technology that measures spatial navigation and gait could improve detection of diseases that cause dementia, according to a new study.
New app puts popular cognitive assessment tool onto smartphones
By
Aaron Dorman
Feb 23, 2024
A new app allows users to take a rapid version of the Montreal Cognitive Assessment on their smartphone, for early warning signs of dementia.
Medicare policy changes tied to drop in hospice use for dementia
May 09, 2022
Immediate and lasting reductions were seen in the share of patients receiving hospice care with the Alzheimer’s disease and related dementia code.
Poststroke cognitive impairment common
May 08, 2023
In some cases, cognitive impairment is reversible, but up to one-third of individuals with stroke develop dementia within five years.
Assisted living, memory care operators elevate dementia caregiving
By
Kimberly Bonvissuto
Jan 03, 2024
Two senior living communities have launched initiatives to elevate care for residents living with dementia and other cognitive issues.
Frontline staff effective in reducing antipsychotic use: study
By
Lois A. Bowers
Apr 17, 2017
The off-label use of antipsychotic medication to treat cognitively impaired residents can be significantly reduced by training frontline staff members to recognize that individuals may exhibit challenging...
Alzheimer’s prediction tool pinpoints where seniors fall along the timeline dementia
By
Aaron Dorman
Feb 05, 2024
A new online tool offers a prediction of how people with early-stage dementia are expected to develop worsening conditions such as Alzheimer’s.
Readmission rates, episode costs increased for patients with dementia
Mar 20, 2023
The cost of a 30-day readmission and total 30-day episode costs were higher for people living with Alzheimer’s disease and related dementias.